The purpose of the Clinical Trials Support Unit (CTSU) is to provide a central Cancer Center resource tocoordinate and assist with all cancer-related clinical research within the affiliated hospitals and ambulatorycare centers of BCM. It will foster the establishment and maintenance of clinical trial related infrastructure,especially for investigators and institutions with less prior experience and knowledge in this area. By thismechanism, it will enable and increase clinical trial enrollment to a wide spectrum of cancer-related studies.The Unit's efforts will particularly target hospitals and institutions with a higher proportion of minority andeconomically disadvantaged patients, providing greater access to participation in clinical research for thesepopulations. In addition the CTSU will facilitate liaison with external co-investigators and cooperative groups,federal agencies, and the pharmaceutical industry.The CTSU will provide three major services to Cancer Center investigators:1) Assistance with regulatory and administrative matters relating to clinical research and trials includingIRB compliance and approval, ongoing amendments and renewal, external agency compliance (suchas the FDA), maintenance of regulatory files, and assistance with internal and external audits;2) Provision of research nursing/clinical trials management especially to less experienced investigatorsor those with limited programs;3) Provision of data management and bioinformatics expertise including database instruction andmaintenance and internal audits.The CTSU will thus provide efficient, cost-effective support to aid Cancer Center investigators in the conductof scientifically valuable cancer clinical trials and will improve access to these trials, especially forunderserved minorities. The main offices of the CTSU are located within the Cancer Center administrativeoffices on the fourth floor of the Cullen Bldg at Baylor College of Medicine. Satellite offices for ResearchNursing/Research Coordinators are located in each of the College's major affiliated clinical facilities includingthe Baylor Ambulatory Care Clinic, St. Luke's Episcopal Hospital, Texas Children's Hospital, the Ben TaubGeneral Hospital, and the Michael E. DeBakey VA Medical Center. The Resource Leader is Martha Mims,M.D./Ph.D.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
1P30CA125123-01
Application #
7514693
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-07-01
Project End
2010-06-30
Budget Start
2007-07-01
Budget End
2008-06-30
Support Year
1
Fiscal Year
2007
Total Cost
$102,504
Indirect Cost
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Boudreaux, Seth P; Duren, Ryan P; Call, Steven G et al. (2018) Drug targeting of NR4A nuclear receptors for treatment of acute myeloid leukemia. Leukemia :
Sukumaran, Sujita; Watanabe, Norihiro; Bajgain, Pradip et al. (2018) Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment. Cancer Discov 8:972-987
Kaochar, Salma; Mitsiades, Nicholas (2018) A Novel Mechanism to Drive Castration-Resistant Prostate Cancer. Trends Endocrinol Metab 29:366-368
Johnston, A N; Bu, W; Hein, S et al. (2018) Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions. Breast Cancer Res 20:42
Ostrom, Quinn T; Kinnersley, Ben; Wrensch, Margaret R et al. (2018) Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21. Sci Rep 8:7352
Chen, Fengju; Zhang, Yiqun; Varambally, Sooryanarayana et al. (2018) Molecular Correlates of Metastasis by Systematic Pan-Cancer Analysis Across The Cancer Genome Atlas. Mol Cancer Res :
Morita, Daisuke; Nishio, Nobuhiro; Saito, Shoji et al. (2018) Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells. Mol Ther Methods Clin Dev 8:131-140
Bajgain, Pradip; Tawinwung, Supannikar; D'Elia, Lindsey et al. (2018) CAR T cell therapy for breast cancer: harnessing the tumor milieu to drive T cell activation. J Immunother Cancer 6:34
Badr, Hoda; Herbert, Krista; Bonnen, Mark D et al. (2018) Dyadic Coping in Patients Undergoing Radiotherapy for Head and Neck Cancer and Their Spouses. Front Psychol 9:1780
Bollard, Catherine M; Tripic, Tamara; Cruz, Conrad Russell et al. (2018) Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma. J Clin Oncol 36:1128-1139

Showing the most recent 10 out of 991 publications